Skip to Main Content

Paper Details

miR-223-3p and miR-24-3p as novel serum-based biomarkers for myotonic dystrophy type 1.
Mol Ther Methods Clin Dev
6
2021
Author NameAffiliation
Tassos C KyriakidesYale Center for Analytical Sciences, Yale School of Public Health
Gr??inne S GormanInstitute of Neuroscience, University of Newcastle
Hanns Lochm??llerMedical Centre-University of Freiburg
Hanns Lochm??llerChildren's Hospital of Eastern Ontario Research Institute, The Ottawa Hospital, and Brain and Mind Research Institute, University of Ottawa
  • 1 - 4

Datasets